Atrial fibrillation in patients with systolic heart failure:pathophysiology mechanisms and management
Ioanna Koniari1
Eleni Artopoulou2
Dimitrios Velissaris2
Nicholas Kounis3
Grigorios Tsigkas3
1.Manchester Heart Institute,Manchester University Foundation Trust,Manchester,United Kingdom2.Department of Internal Medicine,University Hospital of Patras,Patras,Greece3.Department of Cardiology,University Hospital of Patras,Patras,Greece
摘要：Heart failure (HF) and atrial fibrillation (AF) demonstrate a constantly increasing prevalence during the 21st cen-tury worldwide,as a result of the aging population and the successful interventions of the clinical practice in the deterioration of adverse cardiovascular outcomes.HF and AF share common risk factors and pathophysiological mechanisms,creating the base of a constant interrelation.AF impairs systolic and diastolic function,resulting in the increasing incidence of HF,whereas the structural and neurohormonal changes in HF with preserved or reduced ejection fraction increase the possibility of the AF devel-opment.The temporal relationship of the development of either condition affects the diagnostic algorithms,the prognosis and the ideal therapeutic strategy that leads to euvolaemia,management of non-cardiovascular comorbidities,control of heart rate or res-toration of sinus rate,ventricular synchronization,prevention of sudden death,stroke,embolism,or major bleeding and mainten-ance of a sustainable quality of life.The indicated treatment for the concomitant HF and AF includes rate or/and rhythm control as well as thromboembolism prophylaxis,while the progress in the understanding of their pathophysiological interdependence and the introduction of the genetic profiling,create new paths in the diagnosis,the prognosis and the prevention of these diseases.
机标关键词：
论文发表日期：2021-05-28
在线出版日期：2025-08-15（本平台首次上网日期，不代表文献的发表时间）
页数：22( 376-397 )